Fusion Antibodies plc (AIM: FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 9.40
+0.25 (2.73%)
Jan 22, 2025, 12:14 PM GMT+1
Fusion Antibodies Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 1.8 | 1.14 | 2.9 | 4.8 | 4.17 | 3.9 | Upgrade
|
| Revenue Growth (YoY) | 14.12% | -60.84% | -39.55% | 15.22% | 6.93% | 78.51% | Upgrade
|
| Cost of Revenue | 1.44 | 1.18 | 2.33 | 2.33 | 2.14 | 2.12 | Upgrade
|
| Gross Profit | 0.36 | -0.05 | 0.57 | 2.47 | 2.02 | 1.77 | Upgrade
|
| Selling, General & Admin | 1.8 | 2.01 | 3.1 | 3.03 | 2.74 | 2.26 | Upgrade
|
| Research & Development | -0.01 | - | - | - | - | - | Upgrade
|
| Other Operating Expenses | -0.01 | -0.01 | -0.01 | -0.03 | -0.19 | -0.06 | Upgrade
|
| Operating Expenses | 2.03 | 2.24 | 3.43 | 3.79 | 3.27 | 2.83 | Upgrade
|
| Operating Income | -1.66 | -2.29 | -2.86 | -1.33 | -1.25 | -1.06 | Upgrade
|
| Interest Expense | -0 | -0.01 | -0 | -0.01 | -0.02 | -0.02 | Upgrade
|
| Interest & Investment Income | 0.01 | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -1.66 | -2.29 | -2.86 | -1.33 | -1.26 | -1.07 | Upgrade
|
| Pretax Income | -1.66 | -2.29 | -2.86 | -1.33 | -1.26 | -1.07 | Upgrade
|
| Income Tax Expense | -0.03 | -0.06 | -0.26 | -0.13 | 1.64 | -0.38 | Upgrade
|
| Net Income | -1.63 | -2.23 | -2.6 | -1.2 | -2.9 | -0.7 | Upgrade
|
| Preferred Dividends & Other Adjustments | -0.04 | -0.04 | - | - | - | - | Upgrade
|
| Net Income to Common | -1.59 | -2.19 | -2.6 | -1.2 | -2.9 | -0.7 | Upgrade
|
| Shares Outstanding (Basic) | 80 | 56 | 26 | 26 | 25 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 80 | 56 | 26 | 26 | 25 | 22 | Upgrade
|
| Shares Change (YoY) | 120.63% | 113.55% | 0.27% | 1.91% | 15.24% | - | Upgrade
|
| EPS (Basic) | -0.02 | -0.04 | -0.10 | -0.05 | -0.11 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.04 | -0.10 | -0.05 | -0.11 | -0.03 | Upgrade
|
| Free Cash Flow | -1.17 | -1.77 | -1.87 | -0.59 | -1.5 | -0.27 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.07 | -0.02 | -0.06 | -0.01 | Upgrade
|
| Gross Margin | 20.20% | -3.96% | 19.79% | 51.39% | 48.60% | 45.49% | Upgrade
|
| Operating Margin | -92.23% | -201.32% | -98.52% | -27.61% | -29.99% | -27.19% | Upgrade
|
| Profit Margin | -88.29% | -192.78% | -89.49% | -25.01% | -69.60% | -17.89% | Upgrade
|
| Free Cash Flow Margin | -65.04% | -155.90% | -64.39% | -12.25% | -36.04% | -6.91% | Upgrade
|
| EBITDA | -1.51 | -2.07 | -2.51 | -0.65 | -0.61 | -0.51 | Upgrade
|
| EBITDA Margin | -83.85% | -182.13% | -86.56% | -13.48% | -14.60% | -13.02% | Upgrade
|
| D&A For EBITDA | 0.15 | 0.22 | 0.35 | 0.68 | 0.64 | 0.55 | Upgrade
|
| EBIT | -1.66 | -2.29 | -2.86 | -1.33 | -1.25 | -1.06 | Upgrade
|
| EBIT Margin | -92.23% | -201.32% | -98.52% | -27.61% | -29.99% | -27.19% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.